Sense raises € 4.5 million to improve measurement of blood pressure


The Danish company Sense A/S just raised € 4.5 million for their groundbreaking medical technology for blood pressure measurement. The technology works seamlessly and will remedy incorrect diagnostics of hypertension at the physicians' offices, which themselves can cause elevated readings. The total investment from venture fund SEED Capital and Vækstfonden will be used to refine the product and for commercial launch in 2013.

High blood pressure affects more than ¼ of the Western world population and it is estimated that up to 12% of all deaths can be linked to this disorder. Hypertension is therefore one of the world's largest disease areas and the most important factor in the treatment of this is an accurate diagnosis. Current diagnostic solution of choice is the measurement of blood pressure at the physicians' offices, and typically using the cuff method. However this solution has a number of challenges including discomfort with the measurement itself and nervousness during the consultation which both may contribute to erroneous measurements. In addition, the realization is that a variety of cardiovascular diseases can be diagnosed much better by measuring blood pressure over a standard 24-hour circadian rhythm, and for this the cuff method is not very suitable.

The Danish company Sense A/S develops ContiPress™, which continuously measures the patient's blood pressure 24 hours a day, down to every 10 second day and night, without the user noticing. ContiPress™ consists of an intelligent patch, which the doctor or nurse places on the patient's upper arm. From there, the unit monitors the patient's blood pressure over 24 hours and stores the data for subsequent analysis via an enclosed piece of software. The result is comprehensive data about the patient's blood pressure over 24 hours and thus an optimal basis for making the correct diagnosis.

Sense has raised € 4.5 million in an investment round with venture fund SEED Capital and Vækstfonden. It is the company third round, since it was founded in 2006 in connection with an investment from SEED Capital. Second round of investment came from SEED Capital and Vækstfonden in 2010. ContiPress™ is currently a prototype that has been clinically tested on people with very large differences in both blood pressure, BMI (body mass index) and age with promising results that verify the measurement principle. The investment round will be used to refine the device and try ContiPress™ in a more extensive clinical testing within the expected commercial launch.

More info: 

News archive

  • 2014-06-27

    New ownership will accelerate Libratones growth

    A Hong Kong based consortium has entered into an agreement to acquire a majority shareholding in the Danish wireless speaker company Libratone A/S. The consortium consists of financially strong Asian business people and Libratone’s management team.

  • 2014-06-27

    Observe Medical cancel plans to list on OMX First North

    Observe Medical has canceled their planned listing on OMX First North in Stockholm. The process has been canceled because of the increased interest in the company from both investors and the medical industry.

  • 2014-06-26

    DTU Symbion Innovation is one of the top performing university incubators in the world

    DTU Symbion Innovation has been ranked as number 12 on UBI Index’s list of the world’s best university incubators.

  • 2014-06-17

    Templafy receives big investment from SEED Capital and Sunstone

    The Danish startup Templafy has received more than DKK 10 million from SEED Capital and Sunstone. Both venture capital companies are excited about the investment and the prospects of the company.

  • 2014-06-16

    Bownty buys Spanish competitor and becomes largest Groupon-portal in Europe

    Danish startup Bownty has acquired their Spanish competitor Yunait. The acquisition makes Bownty the largest Groupon aggregator in Europe with over half a million experiences booked each year.

  • 2014-06-10

    SiOx receives DKK 8M investment from Innovationsfonden

    SiOx has together with partners Alfa Laval, Elplatek and DTU mechanical engineering recieved a grant for the project “Quartz Coated Metal for Hygienic Applications”. The project runs for 3 years with a total budget af 15 mio. DKK. of which the grants covers 8 mio. DKK.

  • 2014-06-03

    Observe Medical lists on OMX First North

    The Danish-Swedish medtech company Observe Medical has listed on the OMX First North stock exchange in Stockholm. Observe Medical produces medtech equipment for use in intensive care.

  • 2014-05-21

    Mofibo and TDC enter strategic partnership

    Danish E-book store Mofibo and telecommunication giants TDC has just recently entered a strategic partnership. Clients at TDC are now able to subscribe to Mofibo at a lowered monthly fee and even get a one month free subscription.

  • 2014-05-19

    The SL-Deck has been chosen for Krøyers Plads

    Abeo and the concrete manufacturer Perstrup has been thriving ever since their partnership started earlier this year. They have been delivering high quality concrete solutions to the Danish manufacturing industry and have just received another high profile order.

  • 2014-04-29

    Vækstfonden releases report on Danish Venture Capital firms

    Vækstfonden has just released a new report on Danish venture capital firms. The report contain a lot of information on who receives venture capital; which field the companies are in, the age and background of recipients and the much more.




Where to meet us

Press Kit

SEED Capital Ulla Brockenhuus-Schack

SEED Capital logo
Download as png (8 kb)
Download as eps (374 kb)

Ulla Brockenhuus-Schack
Download as jpg (1.1 mb)

Download our full press kit here

Contact Information
Communications Manager: Esben Søndergaard
Phone: +45 2594 0190